Enhanced intra-tumor heterogeneity was directly correlated with increased mortality; in particular, high heterogeneity and p53 mutation positivity were associated with higher mortality rates in a large cohort study of head and neck cancer [19]. Here, TP53 is linked to head and neck cancer.